Glaxowellcome Introducing a Second Migraine Case Study

Total Length: 544 words ( 2 double-spaced pages)

Total Sources: 1+

Page 1 of 2

True that the existence of both which is intended for a similar use, operation or treatment might cause confusion and a question on which is a better product. In this case the replacement of Imigran with the new medication Naramig was the best choice among the other 4 options. With this decision it only proves to its customers, hospitals and patients that the new drug is an improved medication for migraines. As it was noted in this article:

The results showed that the replacement strategy met Glaxo U.K. expectations.

Naramig proved to be effective for migraine headaches in the majority of patients.

4. How should GlaxoWellcome position Amerge in the United States?

Considering several factors which are primarily different from UK, the U.S. market is broader in terms of population and territory.

Stuck Writing Your "Glaxowellcome Introducing a Second Migraine" Case Study?

Difference in health care system is also a factor to be considered. In my opinion, the alternative positioning would fit the U.S. market. Here Naramig/Amerge would be an alternative medication of Imigran/Imitrex, The wide and broad market of the U.S. could be a stronghold market for both products, Amerge and Imitrex. This option in turn can also hamper the entrance of Zenecas Zomig as noted on this article:

The positive aspects of the alternative strategy were that it could detract from competitor noise and could in fact devalue the image of the second-generation triptan......

Show More ⇣


     Open the full completed essay and source list


OR

     Order a one-of-a-kind custom essay on this topic


sample essay writing service

Cite This Resource:

Latest APA Format (6th edition)

Copy Reference
"Glaxowellcome Introducing A Second Migraine" (2005, July 29) Retrieved May 14, 2024, from
https://www.aceyourpaper.com/essays/glaxowellcome-introducing-second-migraine-67931

Latest MLA Format (8th edition)

Copy Reference
"Glaxowellcome Introducing A Second Migraine" 29 July 2005. Web.14 May. 2024. <
https://www.aceyourpaper.com/essays/glaxowellcome-introducing-second-migraine-67931>

Latest Chicago Format (16th edition)

Copy Reference
"Glaxowellcome Introducing A Second Migraine", 29 July 2005, Accessed.14 May. 2024,
https://www.aceyourpaper.com/essays/glaxowellcome-introducing-second-migraine-67931